Shyam Sundar Selected Research

Shyam Sundar Research Topics

Disease

171	Visceral Leishmaniasis (Kala Azar) 08/2022 - 09/2002
40	Leishmaniasis 08/2022 - 12/2002
37	Infections 05/2022 - 10/2002
7	Neoplasms (Cancer) 10/2020 - 03/2008
6	Coinfection 01/2019 - 11/2008
5	Parasitic Diseases (Parasitic Disease) 01/2019 - 01/2012
5	Body Weight (Weight, Body) 04/2013 - 11/2002
4	Neglected Diseases 08/2022 - 01/2015
4	Inflammation (Inflammations) 01/2022 - 01/2016
4	Communicable Diseases (Infectious Diseases) 01/2021 - 01/2013
4	Fever (Fevers) 08/2016 - 06/2007
4	Acquired Immunodeficiency Syndrome (AIDS) 08/2016 - 01/2014
3	Asymptomatic Infections 01/2022 - 06/2012
3	Hypersensitivity (Allergy) 08/2016 - 01/2012
3	Malaria 07/2012 - 02/2008
3	Vomiting 06/2007 - 11/2002
2	Pain (Aches) 07/2020 - 06/2007
2	Papillomavirus Infections 12/2018 - 01/2016
2	Tuberculosis (Tuberculoses) 01/2014 - 02/2008
2	Cardiotoxicity 01/2014 - 12/2010
2	Anemia 01/2011 - 04/2004
2	Hemolysis 01/2011 - 04/2004
2	Cutaneous Leishmaniasis 04/2009 - 12/2002
2	Diarrhea 01/2004 - 11/2002
1	Protozoan Infections 01/2022
1	Cytokine Release Syndrome 01/2021
1	Chronic Disease (Chronic Diseases) 10/2020
1	Dry Socket (Alveolar Osteitis) 07/2020
1	Breast Neoplasms (Breast Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

31	Pharmaceutical PreparationsIBA 01/2021 - 12/2002
29	miltefosine (Impavido)IBA 01/2019 - 11/2002
24	AntigensIBA 01/2021 - 08/2005
21	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2009
21	AntimonyIBA 01/2020 - 12/2002
19	Amphotericin B (Amphotericin)FDA LinkGeneric 08/2022 - 11/2002
19	VaccinesIBA 01/2022 - 12/2006
14	liposomal amphotericin B FDA Link 08/2022 - 12/2002
11	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 11/2021 - 06/2007
10	Interleukin-10 (Interleukin 10)IBA 01/2020 - 04/2007
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2008
7	CytokinesIBA 01/2018 - 01/2012
6	Immunoglobulin G (IgG)IBA 01/2019 - 05/2010
6	EnzymesIBA 01/2019 - 09/2004
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 06/2012
5	Messenger RNA (mRNA)IBA 04/2019 - 04/2007
5	Interleukin-12 (IL 12)IBA 01/2016 - 01/2012
5	deoxycholate drug combination amphotericin BIBA 01/2014 - 02/2004
4	N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA 06/2017 - 01/2012
4	SodiumIBA 08/2015 - 08/2003
4	gluconic acid (gluconate)FDA LinkGeneric 08/2015 - 08/2003
4	Antimony Sodium Gluconate (Sodium, Stibogluconate)IBA 02/2015 - 06/2005
3	ChemokinesIBA 01/2021 - 10/2014
3	Imipramine (Janimine)FDA LinkGeneric 01/2020 - 01/2012
3	ImmunosorbentsIBA 01/2019 - 09/2004
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 07/2011
3	Interferon-gamma (Interferon, gamma)IBA 01/2018 - 04/2011
3	ArsenicIBA 03/2015 - 09/2011
3	18S Ribosomal RNAIBA 06/2012 - 10/2010
3	8-aminoquinolineIBA 06/2011 - 12/2002
2	AmphiregulinIBA 01/2022 - 01/2022
2	LigandsIBA 01/2022 - 08/2012
2	Biological ProductsIBA 08/2021 - 07/2012
2	Lipid NanoparticlesIBA 08/2021 - 01/2020
2	InterferonsIBA 01/2021 - 01/2019
2	ArginaseIBA 01/2020 - 04/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 12/2017
2	CreatinineIBA 09/2019 - 09/2007
2	Peptides (Polypeptides)IBA 01/2019 - 09/2002
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2019 - 01/2018
2	tryparedoxin peroxidaseIBA 01/2018 - 04/2015
2	Interleukin-4 (Interleukin 4)IBA 01/2018 - 01/2012
2	LipidsIBA 01/2016 - 02/2004
2	trypanothione reductaseIBA 01/2015 - 03/2014
2	Sulfhydryl Compounds (Thiols)IBA 12/2014 - 01/2006
2	EmulsionsIBA 09/2014 - 08/2011
2	Fluconazole (Zonal)FDA LinkGeneric 01/2014 - 12/2002
2	Protein Disulfide-IsomerasesIBA 01/2014 - 01/2012
2	AntibodiesIBA 12/2013 - 02/2011
2	leishmaninIBA 11/2011 - 04/2009
2	InsecticidesIBA 12/2010 - 08/2008
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 06/2007 - 01/2004
1	Antiparasitic Agents (Antiparasitics)IBA 08/2022
1	febrifugineIBA 05/2022
1	Growth Factor ReceptorsIBA 01/2022
1	MelatoninIBA 08/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	spearmint oil drug combinations iodoform eugenol butyl aminobenzoateIBA 07/2020
1	Ointments (Pastes)IBA 07/2020
1	ELAV-Like Protein 1IBA 01/2020
1	Interferon Type IIBA 01/2020
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2020

Therapy/Procedure

28	Therapeutics 10/2020 - 12/2002
7	Aftercare (After-Treatment) 02/2021 - 01/2004
6	Drug Therapy (Chemotherapy) 02/2015 - 02/2009
4	Duration of Therapy 01/2018 - 02/2011
3	Immunotherapy 01/2017 - 01/2014
3	Art Therapy 07/2016 - 11/2015
2	Oral Administration 08/2021 - 02/2011
2	Conservative Treatment 09/2011 - 04/2011
2	Injections 06/2007 - 11/2002